BioModics

About:

BioModics develops patented IPN technology that prevents biofilm formation and can be use to develop medical catheters for health care.

Website: http://www.biomodics.com/

Twitter/X: biomodics

Top Investors: Innovation Fund Denmark

Description:

Biomodics is an innovative Danish company focusing on bringing to market medical devices that can prevent hospital acquired infections. Biomodics started as a spinout from the large Danish technological company NKT in 2009. Located at the Danish Technology Institute near Copenhagen, Denmark, the company has built up a strong patent portfolio of new technologies with great promise in the development of new biofilm-resistant medical devices able to prevent the all too frequent hospital acquired infections. Another focus area for the company is the development of innovative drug delivery solutions. Biomodics also specialises in processes using supercritical CO2 such as purification, extraction, and sterilization.

Total Funding Amount:

15M DKK

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Taastrup, Hovedstaden, Denmark

Founded Date:

2010-01-01

Founders:

Peter Thomsen

Number of Employees:

1-10

Last Funding Date:

2016-10-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai